Pharmacy

Carepoint Announces Partnership with New Heritage Capital

Carepoint Pharmacy (“Carepoint”), an end-to-end access hub and dispensing pharmacy serving patients nationwide, announces a new partnership with and investment from New Heritage Capital (“Heritage”), a Boston-based private equity firm focused on partnering with high-growth, founder-owned businesses. Founded in 2012, Carepoint is the first platform that combines 50-state pharmacy dispensing with comprehensive support services for

Carepoint Announces Partnership with New Heritage Capital Read More »

Earth Science Tech, Inc. (ETST) Expands National Footprint with Strategic Acquisition of California Compounding Pharmacy, Meduvo LLC

Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on a diversified portfolio, announces the acquisition of Meduvo LLC, a compounding pharmacy based in La Verne, California. The acquisition serves as an immediate growth catalyst, establishing a highly strategic West Coast operational hub and expanding ETST’s network to 34

Earth Science Tech, Inc. (ETST) Expands National Footprint with Strategic Acquisition of California Compounding Pharmacy, Meduvo LLC Read More »

CVS Blows Past Estimates, Hikes Guidance as Insurance Unit Continues to Improve

CVS Health blew past second-quarter earnings and revenue estimates and raised its 2026 guidance, as its insurance unit Aetna shows signs of recovery. In a release, CVS said the higher profit guidance reflects increases in its insurance and retail pharmacy segment, but noted that the company is maintaining a “cautious view” for the rest of

CVS Blows Past Estimates, Hikes Guidance as Insurance Unit Continues to Improve Read More »

FDA Advisers Recommend Relaxing US Rules on Compounding Peptides

Outside advisers to the U.S. Food and Drug Administration recommended broader access to six unapproved peptides, capping ‌a two-day review that backed most of the compounds despite the health regulator’s staff concerns about limited safety and effectiveness data. Over the course of the meeting held on Thursday and Friday, the panel voted to recommend the

FDA Advisers Recommend Relaxing US Rules on Compounding Peptides Read More »

Scroll to Top